HSE: No patients given at-risk chemo after recall

The HSE has said that no patient received potentially contaminated chemotherapy after it issued a recall last Monday.
HSE: No patients given at-risk chemo after recall
Mon, 19 Oct, 2015 - 01:00
Evelyn Ring

The potentially contaminated chemotherapy was used in the treatment of cancer patients during the period October 2-9 only.

A cancer patient told RTÉ’s Liveline on Friday that she had been advised last Thursday that she might have been treated with contaminated product the previous day.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €10/month. Ts&Cs apply.

WhatsApp logo

Irish Examiner’s WhatsApp channel

More in this section

British-Irish Intergovernmental Conference New law will make it harder to hold up housing and infrastructure projects
Irish Government urged to 'hold its resolve' and pass the Occupied Territories Bill Irish Government urged to 'hold its resolve' and pass the Occupied Territories Bill
Meath footballer with MS urges people to support readathon Meath footballer with MS urges people to support readathon
Chemotherapy drug recallPlace: DublinOrganisation: HSEOrganisation: RTÉOrganisation: Fanning CompoundingOrganisation: Health Products Regulatory AuthorityOrganisation: HPRAOrganisation: Fannin CompoundingOrganisation: Irish Cancer Society
<p>Mixed martial arts fighter Conor McGregor Photo: Irish Examiner </p>

Conor McGregor pulls out of presidential election race

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited